Clin2
NCT05973084Possibly a fitRecruiting

COVID spread study in Malawi households and vaccine recipients

SARS CoV 2 InfectionSARS CoV 2 Vaccination

Part of Infections, Lungs & breathing clinical trials.

This study tracks how COVID-19 spreads and causes illness in real households in Blantyre, Malawi, and compares groups after infection or vaccination. If you qualify, you’ll do follow-up testing and visits for several months.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,500 people
Ages
5 years to 75 years
Study type
Observational

Who can take part

  • Be age 5–75 (or age 18–75 if you are joining the vaccine group)
  • Live in Blantyre and plan to stay near the study health centers for about 6 months
  • Have COVID symptoms and a confirmed COVID test (for the “index case” group) OR be a household contact of a confirmed case OR plan to receive the AZ/JJ vaccine (for vaccine group)
  • Have not had a COVID-19 vaccine dose in the last 3 months (for index and household groups) or have never had a prior COVID vaccine dose (for vaccine group)
  • Be willing to follow the study schedule and attend follow-up visits
  • For some groups: not be pregnant at the enrollment visit; and not use cotrimoxazole prophylaxis long-term

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07030075Recruiting
Flu and respiratory infection study in Lusaka

This study looks at flu-like symptoms and other respiratory infections in adults in Lusaka, Zambia. It aims to understand how these infections affect people with and without HIV, and may help improve care.

Lusaka, Lusaka Province
NCT07085611Recruiting
Studying vaccine and antibody protection in adults

This trial checks how well antibodies from COVID-19 or monkeypox vaccines or treatments work in adults. It helps researchers understand your protection level.

Orléans
NCT05571735Recruiting
COVID vaccine immune response study in people with tuberculosis

This study measures how strongly your immune system responds to COVID-19 vaccines. It includes people with newly diagnosed tuberculosis and a healthier comparison group, aiming to understand vaccine immune effects and safety.

Mae Ramat, Changwat Tak
NCT04582903Recruiting
Send-in sample collection study for immune response to respiratory viruses

This study collects sent-in samples to better understand how your immune system responds during a COVID-19–like illness and after you recover. It may help researchers learn why some people get sick and others stay uninfected, and how immune protection works over time.

Rockville, Maryland
NCT05858502Recruiting
Study immune response to COVID-19 and improve testing

This study looks at how the immune system in the body responds to different COVID-19 virus variants. It may help improve how COVID-19 is diagnosed by comparing people who are currently infected and those who are not.

Paris
NCT07358910Recruiting
Tracking infectious diseases in communities

This study looks at how infections spread in villages in Cambodia. If you live in a participating village, you might help us understand and prevent disease outbreaks.

Phnom Penh, Phnom Penh

Hear when a new SARS CoV 2 Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.